USANA Health Sciences, Inc. (NYSE:USNA) Director Gilbert A. Fuller sold 1,710 shares of the business’s stock in a transaction on Thursday, October 26th. The shares were sold at an average price of $67.01, for a total value of $114,587.10. Following the sale, the director now owns 1,710 shares in the company, valued at $114,587.10. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Shares of USANA Health Sciences, Inc. (NYSE:USNA) opened at 65.90 on Tuesday. The company has a market capitalization of $1.61 billion, a price-to-earnings ratio of 17.12 and a beta of 1.09. USANA Health Sciences, Inc. has a 1-year low of $52.55 and a 1-year high of $71.00. The company’s 50 day moving average price is $59.68 and its 200-day moving average price is $60.77.

USANA Health Sciences (NYSE:USNA) last announced its earnings results on Tuesday, October 24th. The company reported $1.02 EPS for the quarter, topping the Zacks’ consensus estimate of $0.91 by $0.11. USANA Health Sciences had a return on equity of 26.54% and a net margin of 8.79%. The company had revenue of $261.77 million for the quarter, compared to analysts’ expectations of $259.52 million. During the same period last year, the firm earned $2.40 EPS. USANA Health Sciences’s revenue for the quarter was up 3.0% compared to the same quarter last year. On average, equities analysts forecast that USANA Health Sciences, Inc. will post $3.87 earnings per share for the current year.

USANA Health Sciences declared that its Board of Directors has approved a share buyback program on Tuesday, July 25th that authorizes the company to repurchase $64.60 million in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 46% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company’s board believes its shares are undervalued.

TRADEMARK VIOLATION WARNING: “USANA Health Sciences, Inc. (USNA) Director Gilbert A. Fuller Sells 1,710 Shares” was reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this news story on another publication, it was copied illegally and republished in violation of international copyright law. The original version of this news story can be viewed at https://theolympiareport.com/2017/10/31/usana-health-sciences-inc-usna-director-gilbert-a-fuller-sells-1710-shares.html.

A number of analysts recently issued reports on USNA shares. BidaskClub upgraded USANA Health Sciences from a “sell” rating to a “hold” rating in a research note on Thursday, October 26th. Pivotal Research boosted their price objective on USANA Health Sciences from $70.00 to $80.00 and gave the company a “buy” rating in a research note on Wednesday, October 25th.

Institutional investors have recently made changes to their positions in the stock. Ameriprise Financial Inc. raised its holdings in USANA Health Sciences by 19.6% during the first quarter. Ameriprise Financial Inc. now owns 44,563 shares of the company’s stock valued at $2,567,000 after acquiring an additional 7,305 shares during the period. JPMorgan Chase & Co. raised its holdings in USANA Health Sciences by 1.2% during the first quarter. JPMorgan Chase & Co. now owns 16,044 shares of the company’s stock valued at $924,000 after acquiring an additional 196 shares during the period. Victory Capital Management Inc. raised its holdings in USANA Health Sciences by 124.7% during the first quarter. Victory Capital Management Inc. now owns 2,117 shares of the company’s stock valued at $122,000 after acquiring an additional 1,175 shares during the period. American International Group Inc. raised its holdings in USANA Health Sciences by 7.1% during the first quarter. American International Group Inc. now owns 6,392 shares of the company’s stock valued at $368,000 after acquiring an additional 422 shares during the period. Finally, Teachers Advisors LLC raised its holdings in USANA Health Sciences by 2.5% during the first quarter. Teachers Advisors LLC now owns 223,128 shares of the company’s stock valued at $12,852,000 after acquiring an additional 5,451 shares during the period. 44.62% of the stock is currently owned by institutional investors.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.